Rajasthan Suspends State Drug Controller, Halts Kaysons Pharma Medicines After Cough Syrup Deaths
The Rajasthan government has taken strict action following reports of child deaths allegedly linked to contaminated cough syrups. The State has suspended Drug Controller Rajaram Sharma and halted the distribution of all medicines manufactured by Jaipur-based company Kaysons Pharma, officials confirmed on Friday.
Suspension and Ban on Drug Distribution
According to the Medical and Health Department, the supply of all 19 medicines produced by Kaysons Pharma has been stopped until further notice. In addition, distribution of all cough syrups containing Dextromethorphan—a common cough suppressant—has also been suspended across the State.
The government’s decision follows reports that 11 children, including nine from Madhya Pradesh and two from Rajasthan, allegedly died after consuming contaminated cough syrup. The investigation into the cause of death is underway.
Drug Controller Suspended
The government placed State Drug Controller Rajaram Sharma under suspension for allegedly influencing the process of determining drug standards. Officials said that the suspension was necessary to ensure transparency and accountability in the ongoing probe.
Chief Minister Bhajanlal Sharma has directed a comprehensive investigation into the case and ordered strict action against those found responsible. Following his instructions, an expert committee is being formed to examine the matter and submit its findings.
Advisory and Safety Measures
Health Minister Gajendra Singh has also ordered a separate inquiry and directed the department to take immediate measures to protect public health and prevent further incidents.
Principal Secretary Gayatri Rathore of the Medical and Health Department highlighted that the Union Government had already issued an advisory in 2021 against administering Dextromethorphan-based cough syrups to children below four years of age.
Reiterating this warning, the Drug Controller General of India (DCGI) has now advised that such syrups should be administered only to children above five years—and never to children below two years of age.
Clear Warning Labels for Risky Drugs
In response to recent events, the Rajasthan Health Department has directed that all drugs potentially harmful to children and pregnant women must carry clear warning labels. This initiative aims to enhance consumer safety and awareness about the potential side effects of certain formulations.
Public Health Under Scrutiny
The tragedy has once again raised concerns over drug quality control and regulatory oversight in India’s pharmaceutical sector. The incident echoes past global cases where contaminated syrups led to multiple deaths, prompting stricter drug safety norms.
Authorities assure that the State Government will ensure stringent action against any company found guilty of violating drug manufacturing standards. The inquiry committee’s report is expected to play a crucial role in shaping future regulations regarding pediatric medicines.
